West Family Investments’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.05M | Buy |
2,363
+1,015
| +75% | +$452K | 0.27% | 73 |
|
|
2025
Q1 | $654K | Sell |
1,348
-1,304
| -49% | -$632K | 0.25% | 83 |
|
|
2024
Q4 | $1.07M | Sell |
2,652
-12
| -0.5% | -$4.83K | 0.37% | 52 |
|
|
2024
Q3 | $1.24M | Buy |
2,664
+126
| +5% | +$58.6K | 0.42% | 50 |
|
|
2024
Q2 | $1.19M | Hold |
2,538
| – | – | 0.36% | 57 |
|
|
2024
Q1 | $1.06M | Buy |
2,538
+44
| +2% | +$18.4K | 0.33% | 63 |
|
|
2023
Q4 | $1.01M | Hold |
2,494
| – | – | 0.34% | 58 |
|
|
2023
Q3 | $867K | Hold |
2,494
| – | – | 0.3% | 66 |
|
|
2023
Q2 | $878K | Buy |
2,494
+30
| +1% | +$10.6K | 0.34% | 65 |
|
|
2023
Q1 | $776K | Buy |
2,464
+26
| +1% | +$8.19K | 0.31% | 68 |
|
|
2022
Q4 | $704K | Sell |
2,438
-281
| -10% | -$81.1K | 0.24% | 74 |
|
|
2022
Q3 | $787K | Buy |
2,719
+130
| +5% | +$37.6K | 0.33% | 66 |
|
|
2022
Q2 | $730K | Sell |
2,589
-30
| -1% | -$8.46K | 0.29% | 68 |
|
|
2022
Q1 | $683K | Buy |
2,619
+311
| +13% | +$81.1K | 0.19% | 79 |
|
|
2021
Q4 | $507K | Buy |
2,308
+990
| +75% | +$217K | 0.14% | 124 |
|
|
2021
Q3 | $239K | Sell |
1,318
-1,664
| -56% | -$302K | 0.06% | 263 |
|
|
2021
Q2 | $601K | Buy |
+2,982
| New | +$601K | 0.16% | 104 |
|